High-content imaging for automated determination of host-cell infection rate by the intracellular parasite Trypanosoma cruzi
- PMID: 20688189
- PMCID: PMC2964385
- DOI: 10.1016/j.parint.2010.07.007
High-content imaging for automated determination of host-cell infection rate by the intracellular parasite Trypanosoma cruzi
Abstract
Chagas disease affects 8-11 million people, mostly in Latin America. Sequelae include cardiac, peripheral nervous and/or gastrointestinal disorders, thus placing a large economic and social burden on endemic countries. The pathogenesis and the evolutive pattern of the disease are not fully clarified. Moreover, available drugs are partially effective and toxic, and there is no vaccine. Therefore, there is an urgent need to speed up basic and translational research in the field. Here, we applied automated high-content imaging to generate multiparametric data on a cell-by-cell basis to precisely and quickly determine several parameters associated with in vitro infection of host cell by Trypanosoma cruzi, the causative agent of Chagas disease. Automated and manual quantifications were used to determine the percentage of T. cruzi-infected cells in a 96-well microplate format and the data generated was statistically evaluated. Most importantly, this automated approach can be widely applied for discovery of potential drugs as well as molecular pathway elucidation not only in T. cruzi but also in other human intracellular pathogens.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2964385/bin/nihms235270f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2964385/bin/nihms235270f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2964385/bin/nihms235270f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2964385/bin/nihms235270f4.gif)
Similar articles
-
Close encounters between Trypanosoma cruzi and the host mammalian cell: Lessons from genome-wide expression studies.Genomics. 2020 Jan;112(1):990-997. doi: 10.1016/j.ygeno.2019.06.015. Epub 2019 Jun 20. Genomics. 2020. PMID: 31229555 Review.
-
Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.Immunobiology. 2017 Mar;222(3):529-535. doi: 10.1016/j.imbio.2016.10.020. Epub 2016 Oct 29. Immunobiology. 2017. PMID: 27839837
-
Automated high-content assay for compounds selectively toxic to Trypanosoma cruzi in a myoblastic cell line.PLoS Negl Trop Dis. 2015 Jan 23;9(1):e0003493. doi: 10.1371/journal.pntd.0003493. eCollection 2015 Jan. PLoS Negl Trop Dis. 2015. PMID: 25615687 Free PMC article.
-
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.Antimicrob Agents Chemother. 2010 Aug;54(8):3326-34. doi: 10.1128/AAC.01777-09. Epub 2010 Jun 14. Antimicrob Agents Chemother. 2010. PMID: 20547819 Free PMC article.
-
The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?N Biotechnol. 2010 Dec 31;27(6):837-43. doi: 10.1016/j.nbt.2010.02.003. Epub 2010 Feb 19. N Biotechnol. 2010. PMID: 20172059 Review.
Cited by
-
State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation.Res Rep Trop Med. 2023 Jun 14;14:1-19. doi: 10.2147/RRTM.S415273. eCollection 2023. Res Rep Trop Med. 2023. PMID: 37337597 Free PMC article. Review.
-
The translational challenge in Chagas disease drug development.Mem Inst Oswaldo Cruz. 2022 May 23;117:e200501. doi: 10.1590/0074-02760200501. eCollection 2022. Mem Inst Oswaldo Cruz. 2022. PMID: 35613156 Free PMC article. Review.
-
Past and future of trypanosomatids high-throughput phenotypic screening.Mem Inst Oswaldo Cruz. 2022 Mar 11;117:e210402. doi: 10.1590/0074-02760210402. eCollection 2022. Mem Inst Oswaldo Cruz. 2022. PMID: 35293482 Free PMC article.
-
In vitro susceptibility of Trypanosoma cruzi discrete typing units (DTUs) to benznidazole: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2021 Mar 22;15(3):e0009269. doi: 10.1371/journal.pntd.0009269. eCollection 2021 Mar. PLoS Negl Trop Dis. 2021. PMID: 33750958 Free PMC article.
-
Non-invasive monitoring of drug action: A new live in vitro assay design for Chagas' disease drug discovery.PLoS Negl Trop Dis. 2020 Jul 27;14(7):e0008487. doi: 10.1371/journal.pntd.0008487. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32716934 Free PMC article.
References
-
- Chagas C. Nova tripanosomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi, n.g., n. Sp., ajente etiolójico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz. 1909;1:159–218.
-
- Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz. 2007;102 Suppl 1:75–85. - PubMed
-
- Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49:e52–e54. - PubMed
-
- Bradley KK, Bergman DK, Woods JP, Crutcher JM, Kirchhoff LV. Prevalence of American trypanosomiasis (Chagas disease) among dogs in Oklahoma. J Am Vet Med Assoc. 2000;217:1853–1857. - PubMed
-
- Pung OJ, Banks CW, Jones DN, Krissinger MW. Trypanosoma cruzi in wild raccoons, opossums, and triatomine bugs in southeast Georgia, U.S.A. J Parasitol. 1995;81:324–326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources